Tinidazole

Generic Name
Tinidazole
Brand Names
Tindamax
Drug Type
Small Molecule
Chemical Formula
C8H13N3O4S
CAS Number
19387-91-8
Unique Ingredient Identifier
033KF7V46H
Background

A nitroimidazole antitrichomonal agent effective against Trichomonas vaginalis, Entamoeba histolytica, and Giardia lamblia infections.

Indication

For the treatment of trichomoniasis caused by T. vaginalis in both female and male patients. Also for the treatment of giardiasis caused by G. duodenalis in both adults and pediatric patients older than three years of age and for the treatment of intestinal amebiasis and amebic liver abscess caused by E. histolytica in both adults and pediatric patients olde...

Associated Conditions
Amebiasis, Bacterial Vaginosis (BV), Giardiasis, Mixed Vaginal Infections, Nongonococcal urethritis, Sexually Transmitted Disease (STD), Trichomonas Vaginalis Infection, Trichomonas Vaginitis, Vaginal Candidiasis
Associated Therapies
-
Clinical Trials
Related News

Effectiveness of Rifabutin for Treatment of Helicobacter Pylori

First Posted Date
2020-12-03
Last Posted Date
2021-03-10
Lead Sponsor
Rabin Medical Center
Target Recruit Count
300
Registration Number
NCT04652284

Helicobacter Pylori Rescue Treatment Containing Tetracycline in Patients Allergic to Penicillin

First Posted Date
2020-02-11
Last Posted Date
2021-11-18
Lead Sponsor
Shandong University
Target Recruit Count
250
Registration Number
NCT04264663
Locations
🇨🇳

Qilu hospital, Jinan, Shandong, China

Helicobacter Pylori First-line Treatment in Patients Allergic to Penicillin

First Posted Date
2019-10-10
Last Posted Date
2021-11-18
Lead Sponsor
Shandong University
Target Recruit Count
250
Registration Number
NCT04122287
Locations
🇨🇳

Qilu hospital, Jinan, Shandong, China

Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment

First Posted Date
2017-05-03
Last Posted Date
2017-05-03
Lead Sponsor
Yanqing Li
Target Recruit Count
120
Registration Number
NCT03139253

Treatment of Giardia Lamblia Infections in Children

Phase 4
Terminated
Conditions
GIARDIASIS
Interventions
Drug: Metronidazole
Drug: Tinidazole
First Posted Date
2016-10-24
Last Posted Date
2020-11-18
Lead Sponsor
Helsinki University Central Hospital
Target Recruit Count
8
Registration Number
NCT02942485
Locations
🇫🇮

Children's Hospital, HYKS, Helsinki, Finland

Crossover Bioequivalence Study of Tinidazole 500 mg Tablets Under Fed Conditions

Phase 1
Completed
Conditions
Trichomoniasis
Interventions
Drug: Tinidazole
First Posted Date
2012-05-04
Last Posted Date
2018-01-23
Lead Sponsor
Roxane Laboratories
Target Recruit Count
28
Registration Number
NCT01591889
Locations
🇺🇸

Novum Pharmaceutical Research Services, Houston, Texas, United States

Pilot Human Study of Tinidazole Efficacy For Radical Cure Of Plasmodium Vivax

Phase 2
Completed
Conditions
Malaria, Vivax
Interventions
Drug: chloroquine
Drug: Tinidazole
First Posted Date
2008-12-18
Last Posted Date
2012-12-03
Lead Sponsor
Walter Reed Army Institute of Research (WRAIR)
Target Recruit Count
20
Registration Number
NCT00811096
Locations
🇹🇭

Malaria Research Unit, 68/30 Ban Toong Road, P.O. Box 46, Mae Sot, 63110, Tak, Thailand

Tinidazole Versus Cefazolin Antibiotic Prophylaxis of Vaginal and Abdominal Hysterectomy

First Posted Date
2008-11-07
Last Posted Date
2008-11-07
Lead Sponsor
University of Campinas, Brazil
Target Recruit Count
75
Registration Number
NCT00787553
Locations
🇧🇷

University of Campinas, Campinas, SP, Brazil

Tinidazole for Recurrent Bacterial Vaginosis: A Pilot Study

Early Phase 1
Completed
Conditions
Bacterial Vaginosis
Interventions
Drug: Placebo
Drug: tinidazole
First Posted Date
2007-08-02
Last Posted Date
2011-02-18
Lead Sponsor
University of Pittsburgh
Target Recruit Count
37
Registration Number
NCT00510614
Locations
🇺🇸

Magee-Womens Hospital of UPMC, Pittsburgh, Pennsylvania, United States

NGU: Doxycycline (Plus or Minus Tinidazole) Versus Azithromycin (Plus or Minus Tinidazole)

First Posted Date
2006-05-08
Last Posted Date
2019-03-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
305
Registration Number
NCT00322465
Locations
🇺🇸

Delgado Personal Health Center, New Orleans, Louisiana, United States

🇺🇸

University of Alabama Hospital - Infectious Diseases, Birmingham, Alabama, United States

🇺🇸

University of North Carolina School of Medicine - Center for Infectious Diseases, Chapel Hill, North Carolina, United States

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy